Cleerly, Inc.
6
1
3
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Role: lead
Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)
Role: collaborator
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Role: lead
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Role: lead
ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
Role: collaborator
Multicentre Registry of CCTA, IVUS and OCT
Role: lead
All 6 trials loaded